European Commission approves nivolumab plus ipilimumab combination for first-line advanced RCC
The European Commission has approved the nivolumab plus ipilimumab combination [...]
The European Commission has approved the nivolumab plus ipilimumab combination [...]
Results from the phase 3 CARMENA study, published in the [...]
This multicentre analysis of axitinib versus sunitinib used as first-line [...]
The following article from Practice Update discusses the JAVELIN Renal [...]
The following OncLive interview with leading renal cell carcinoma (RCC) expert, Dr [...]
A phase 1 study has evaluated the safety and efficacy [...]
A study investigating the prognostic and predictive value of a [...]
Analysis of the phase 3 CheckMate-214 study has shown that [...]
Results from the KEYNOTE-426 phase 3 study show that the [...]
Results from the JAVELIN Renal 101 phase 3 study to [...]